Meeting Detail

Wednesday, May 12, 2004
3:10 PM ET
Location: Room 160-S, Centre Block
Clerk: François Michaud (613) 998-0424
Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
  • The Honourable Bill Graham, P.C., M.P., Minister of Foreign Affairs
  • The Honourable Lucienne Robillard, P.C., M.P., Minister of Industry
  • Christopher Armstrong, Senior Advisor, HIV/AIDS, Human Rights, Humanitarian Affairs and International Women's Equality Division (Foreign Affairs and International Trade Canada)
  • Susan Bincoletto, Acting Director General, Marketplace Framework Policy Branch (Industry Canada)
  • Sandra Black, Director, Social Development Policies, Policy Branch (Canadian International Development Agency)
  • Adrienne Blanchard, Legal Counsel, Gowling, Lafleur and Henderson (Canada's Research-Based Pharmaceutical Companies)
  • Doug Clark, Senior Project Leader, Patent Policy Directorate (Industry Canada)
  • Éric Dagenais, Director, Patent Policy Directorate (Industry Canada)
  • Jim Keon, President (Canadian Generic Pharmaceutical Association)
  • David K. Lee, Directorate, Office of Patented Medicines and Liaison, Therapeutic Products Directorate, Health Products and Food Branch (Health Canada)
  • Jean-François Leprince, President, Aventis Pharmaceutical, Chair, Rx&D Intellectual Property Committee (Canada's Research-Based Pharmaceutical Companies)
  • Terry McCool, Vice-President, Corporate Affairs, Eli Lilly Canada Inc., Vice-Chair, Rx&D Intellectual Property Committee (Canada's Research-Based Pharmaceutical Companies)
  • Dr. Robert Peterson, Director General, Therapeutic Products Directorate, Health Products and Food Branch (Health Canada)
  • Vishva V. Ramlall, Senior Policy Officer, Corporate Strtegies Branch, Canadian Intellectual Property Office (Industry Canada)
  • Rob Sutherland-Brown, Senior Counsel, Industry Canada Legal Services (Industry Canada)
Bill C-9, An Act to amend the Patent Act and the Food and Drugs Act
  • Clause-by-clause consideration
Meeting with Transcription and Interpretation
Back to top